TY  - BOOK
AU  - Mancher,Michelle
AU  - Leshner,Alan I.
ED  - National Academies of Sciences, Engineering, and Medicine (U.S.).
TI  - Medications for opioid use disorder save lives
T2  - Consensus study report of the National Academies of Sciences, Engineering, Medicine
SN  - 9780309486514
AV  - RC568.O45 
U1  - 615.7/822 23
PY  - 2019///]
CY  - Washington, DC
PB  - National Academies Press
KW  - Opioid abuse
KW  - Treatment
KW  - United States
KW  - Drug addicts
KW  - Rehabilitation
KW  - Opioids
KW  - Overdose
KW  - Brain
KW  - Diseases
KW  - Prevention
KW  - Government policy
KW  - Methadone maintenance
KW  - Buprenorphine
KW  - Therapeutic use
KW  - Naloxone
KW  - Naltrexone
KW  - Drugs
KW  - Opiate Substitution Treatment
KW  - Opioid-Related Disorders
KW  - drug therapy
KW  - Drug Users
KW  - Drug Overdose
KW  - Toxicomanie aux opiacés
KW  - Traitement
KW  - États-Unis
KW  - Toxicomanes
KW  - Réadaptation
KW  - Opioïdes
KW  - Surdosage
KW  - Cerveau
KW  - Maladies
KW  - Méthadone
KW  - Emploi en thérapeutique
KW  - Buprénorphine
KW  - Médicaments
KW  - fast
KW  - Electronic books
N1  - Includes bibliographical references; Introduction -- The effectiveness of medication-based treatment for opioid use disorder -- Treatment with medications for opioid use disorder in different populations -- Medications for opioid use disorder in various treatment settings -- Barriers to broader use of medications to treat opioid use disorder -- Appendixes
N2  - The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already exist--like evidence-based medications--are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed
UR  - https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2186517
ER  -